Skip to main content
Clinical Trials/ACTRN12620000144910
ACTRN12620000144910
Recruiting
未知

A Pilot Study using Non-Contact Smartphone Cough Sound Recordings to Screenfor Chronic Obstructive Pulmonary Disease in an Indigenous Australian AdultPopulation.

ResApp Health0 sites200 target enrollmentFebruary 12, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Sponsor
ResApp Health
Enrollment
200
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2020
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ResApp Health

Eligibility Criteria

Inclusion Criteria

  • Must be able to provide written consent. Adults aged 22 years or older, coughing spontaneously or able to cough voluntarily, attending the study site:
  • 1\. without known acute or chronic respiratory disease
  • (i) with normal spirometry (termed healthy patients) or
  • (ii) with spirometry indicating COPD (termed COPD patients with no previous diagnosis)
  • a. subject must have had a spirometric assessment completed as a result of standard clinical care or be willing to undergo a spirometric assessment OR
  • 2\. with a historical diagnosis of COPD and history of smoking or other environmental exposure, or respiratory symptoms consistent with COPD.
  • a. subject must have had a spirometric assessment completed as a result of standard clinical care or be willing to undergo a spirometric assessment
  • Recruitment will occur at GRAMS \- Geraldton Regional Aboriginal Medical Service, and as such will include an indigenous population.

Exclusion Criteria

  • 1\. Lack of consent
  • 2\. Patients with asthma and asthma\-COPD comorbidity
  • 3\. Unable to provide at least 5 coughs sounds recognized by the study device
  • 4\. Medical contraindication to voluntary cough, including:
  • o Severe respiratory distress
  • o History of pneumothorax
  • o Eye, chest, or abdominal surgery within the past 3 months
  • 5\. Subjects with a clinical diagnosis of Tuberculosis, heart failure, lobectomy, neuromuscular disease or terminal disease
  • 6\. Structural airway disease including laryngo/tracheomalacia
  • 7\. Mechanical ventilation (invasive, CPAP, or BiPAP) or highflow nasal cannula

Outcomes

Primary Outcomes

Not specified

Similar Trials